Anne Byriel Walls

Anne Byriel Walls is an Associate Professor in the Department of Drug Design and Pharmacology at the University of Copenhagen's Faculty of Health and Medical Sciences. Her research focuses on translational and clinical pharmacology with particular expertise in kidney function assessment, neuropharmacology, and biomarker development.

Her educational background includes a Ph.D. in Neuroscience from the Norwegian University of Science and Technology (awarded September 7, 2010) and a Cand. Pharm. (Pharmacist) degree from the University of Copenhagen (awarded February 10, 2006).

Dr. Walls' research interests span multiple interconnected domains of pharmacology. Her work integrates neurochemical research with clinical applications, particularly focusing on GABAergic neurotransmission and brain energy metabolism. She has made significant contributions to the field of renal pharmacology, developing methods for improved glomerular filtration rate estimation and investigating medication safety in kidney disease. Her research on Alzheimer's disease biomarkers demonstrates her interdisciplinary approach connecting neuroscience with clinical diagnostics.

Analysis of her recent publications (2022-2025) reveals a strong focus on clinical applications of pharmacological research, with particular emphasis on kidney function assessment, neuropharmacology, and biomarker validation. Her work often involves large-scale clinical studies and systematic reviews addressing practical challenges in medication management for patients with complex conditions.

Dr. Walls maintains an active research profile with 48 documented research outputs including journal articles, reviews, book chapters, and conference presentations. Her work has been cited in multiple scientific databases and has attracted attention from news outlets and peer review platforms.

She leads the research group at neurometabolism.dk, which focuses on the intersection of neurochemistry and metabolism. Her team collaborates with researchers across multiple countries and disciplines to advance understanding of brain metabolism and its implications for neurological disorders and pharmacological interventions.